Your browser doesn't support javascript.
loading
Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis.
Gyang, Tirisham V; Evans, John P; Miller, Joseph S; Alcorn, Kariss; Peng, Juan; Bell, Erica H; Zeng, Cong; Gumina, Richard; Liu, Shan-Lu; Segal, Benjamin M.
Afiliação
  • Gyang TV; Department of Neurology, The Ohio State University, Columbus, OH 43210, USA.
  • Evans JP; Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
  • Miller JS; Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.
  • Alcorn K; College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Peng J; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
  • Bell EH; Department of Neurology, The Ohio State University, Columbus, OH 43210, USA.
  • Zeng C; Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
  • Gumina R; Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Liu SL; Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
  • Segal BM; Department of Neurology, The Ohio State University, Columbus, OH 43210, USA.
Mult Scler J Exp Transl Clin ; 8(1): 20552173221087357, 2022.
Article em En | MEDLINE | ID: mdl-35342640

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article